Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor(TFPI)

Details for Australian Patent Application No. 2006236698 (hide)

Owner Novartis Vaccines and Diagnostics Inc. Creasey, A.

Inventors Creasey, Abla

Agent FB Rice

Pub. Number AU-A-2006236698

PCT Pub. Number WO2006/113360

Priority 60/671,466 15.04.05 US

Filing date 14 April 2006

Wipo publication date 26 October 2006

International Classifications

A61K 38/57 (2006.01) Medicinal preparations containing peptides

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/113360 Priority application(s): WO2006/113360

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236704-Hybrid LVEDP monitor

2006236695-Multi-action device for inserting an intraocular lens into an eye